Inhibitory effect of curcumin on motility of human oral squamous carcinoma YD‐10B cells via suppression of ERK and NF‐κB activations
- 23 September 2009
- journal article
- research article
- Published by Wiley in Phytotherapy Research
- Vol. 24 (4) , 577-582
Abstract
Oral squamous cell carcinomas (OSCCs) are characterized by a marked propensity for local invasion, so the identification of agents inhibiting the onset and progression of OSCC has recently gained interest. Here, we found that curcumin inhibited cell proliferation and motility with decreased activities of matrix metalloproteinase (MMP)‐2/9 and decreased mRNA expressions of urokinase‐type plasminogen activator (uPA) and its receptor uPAR in the highly invasive human YD‐10B OSCC cells. Western blot analysis showed that curcumin inhibited the activation of MAP kinases (especially ERK) and NF‐κB, which are involved in the transcriptional regulation of proteolytic enzymes. In conclusion, curcumin is one of the strong phytochemicals with antimotility activity of OSCC; the inhibitory effect of curcumin on the motility of YD‐10B cells could result from its potential to inhibit the activation of ERK/MAP kinase and NF‐κB that consequently down‐regulate the mRNA expressions and activities of proteolytic enzymes such as uPA and MMP‐2/9. Copyright © 2009 John Wiley & Sons, Ltd.Keywords
Funding Information
- Korea Research Foundation Grant funded by the Korean Government (KRF-2006-311-E00461)
This publication has 29 references indexed in Scilit:
- Epigallocatechin‐3‐gallate inhibits the invasion of human oral cancer cells and decreases the productions of matrix metalloproteinases and urokinase‐plasminogen activatorJournal of Oral Pathology & Medicine, 2007
- High expression levels of nuclear factor kappa B and gelatinases in the tumorigenesis of oral squamous cell carcinomaHead & Neck, 2006
- Silibinin Inhibits Invasion of Oral Cancer Cells by Suppressing the MAPK PathwayJournal of Dental Research, 2006
- Chemopreventive and therapeutic effects of curcuminCancer Letters, 2005
- Inhibition of growth and survival of human head and neck squamous cell carcinoma cells by curcumin via modulation of nuclear factor‐κB signalingInternational Journal of Cancer, 2004
- uPAR: a versatile signalling orchestratorNature Reviews Molecular Cell Biology, 2002
- Expression of cyclin D1 and GSK-3β and their predictive value of prognosis in squamous cell carcinomas of the tongueOral Oncology, 2002
- Urokinase Receptor and Fibronectin Regulate the ERKMAPK to p38MAPK Activity Ratios That Determine Carcinoma Cell Proliferation or Dormancy In VivoMolecular Biology of the Cell, 2001
- Tumor Dormancy Induced by Downregulation of Urokinase Receptor in Human Carcinoma Involves Integrin and MAPK SignalingJournal of Cell Biology, 1999
- Molecular mechanism of transcriptional activation of human gelatinase B by proximal promoterCancer Letters, 1996